Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
0VB8HF5FT1G9BKyt